IMR Press / JIN / Special Issues / 1617784190875

COVID-19 and its neurological implications

Submission deadline: 30 June 2022
Special Issue Editors
Mila Emerald, MD
Founder & CEO, PHYTOCEUTICALS International TM and NOVOTEK Global Solutions TM, Canada
Interests: Neuroscience; Biophysics; Cellular ; molecular biology; Phytopharmacology; Pharmacognosy; Drugs discovery and drugs delivery systems
Special Issue Information

Dear Colleagues,

Current research and evidence state that there are numerous novel overlapping pathways shared by neurodegenerative disorders and diseases like cancer. These diseases are defined by a set of molecular determinants that are either complementarily deregulated or share remarkably overlapping functional paths. The inter-dependent regulation of brain cancers and neurodegeneration mediated by intercellular communication between tumor and neuronal cells in the brain through the extracellular microenvironment is necessary in understanding this unique connection. One of such pivotal pillars which plays a huge role in both maladies is unfolded protein response (UPR). Coronavirus Disease (COVID-19) caused by SARS-CoV-2 infection, is known to affect a variety of organs leading to irreversible pathological conditions. By direct infection of neural cells causing distortion in the functioning of the neuronal networks and profound damage of nervous tissue in both, central (CNS) and peripheral nervous system (PNS), SARS-CoV-2 significantly affects functions of human brain  by triggering systemic inflammation, ischemia, and evoking anosmia, cognitive problems, meningitis, encephalopathy, stroke, paralysis, cranial nerve deficits, sleep disturbances, dizziness, hallucinations, delirium, seizures,  and on a long run - depression, insomnia, cognitive decline, accelerated aging, OCD, memory loss, and fast progressing Parkinson’s or Alzheimer’s disease. The main scope of this special issue is focused on the critical overview of the neuronal, cellular, and molecular basis of several neurological problems cause by SARS-CoV-2 available up to date, from which we will be able to create future hypotheses, gain deep understanding of detailed mechanisms for its neurological implications, and build on a solid platform for the further development of the most effective therapeutic strategies.


Prof. Dr. Mila Emerald

Guest Editor

Cognitive deficits
Molecular mechanisms
Neurological implications
Therapeutic ctrategies
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1900 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (1 Paper)
Open Access Review
Neurological Sequelae of COVID-19
Samuel J. Ahmad, Chaim M. Feigen, Juan P. Vazquez, Andrew J. Kobets, David J. Altschul
J. Integr. Neurosci. 2022, 21(3), 77;
(This article belongs to the Special Issue COVID-19 and its neurological implications)
Back to top